Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy
- 1 July 1994
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 36 (1) , 55-61
Abstract
Severe cholinergic loss occurs in the brains of patients with progressive supranuclear palsy. To evaluate the functional implications of this neuronal deficit, dose‐response curves were obtained in patients with progressive supranuclear palsy and normal control subjects undergoing intravenous cholinergic blockade (scopolamine) and stimulation (physo‐stigmine). Physostigmine had no significant neurobehavioral effects at any does in patients with progressive supranuclear palsy. Scopolamine, at low and medium doses, significantly impaired memory performance of both groups, but worsened the gait of only the patients. High‐dose scopolamine, which could not be tolerated by the patients, resulted in gait deterioration among control subjects. Thus, patients with progressive supranuclear palsy have increased sensitivity to cholinergic blockade compared to control subjects. Since loss of cholinergic neurons appears to contribute to the pathogenesis of certain cognitive and motor deficits found in progressive supranuclear palsy, the use of oral anticholinergics should ordinarily be avoided in this disorder. On the other hand, physostigmine at clinically tolerated dose levels seems to be terapeutically ineffective.Keywords
This publication has 26 references indexed in Scilit:
- Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- The Clinical Validity of the Mattis Dementia Rating Scale in Staging Alzheimer's DementiaJournal of Geriatric Psychiatry and Neurology, 1991
- Frontal Lobe Function in Progressive Supranuclear PalsyArchives of Neurology, 1990
- Physostigmine treatment of progressive supranuclear palsyAnnals of Neurology, 1989
- Rigidity and dorsiflexion of the neck in progressive supranuclear palsy and the interstitial nucleus of Cajal.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- A comparison of the effects of two inhibitors on brain cholinesteraseNeuropharmacology, 1987
- Dopaminergic and cholinergic lesions in progressive supranuclear palsyAnnals of Neurology, 1985
- Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markersAnnals of Neurology, 1985
- Progressive supranuclear palsy: Postmortem chemical analysisAnnals of Neurology, 1985
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967